Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide6 min read

TrimRx Cost 2026 (Trim Rx): $149 Dose-Flat Pricing Explained

TrimRx (Trim Rx) charges $149/month for semaglutide, the same at every dose, and $259 for tirzepatide with no contract. The discounts and year-cost math.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • TrimRx runs $149/month for compounded semaglutide (a $140 discount applied, the same price at every dose) and $259/month for tirzepatide, with medication, consultations and clinical support included.
  • No long-term contract: you pay the listed rate month-to-month with the right to stop at any renewal, or opt into a multi-month plan for a lower rate - chosen per renewal, not at signup.
  • Month-to-month for a year costs $1,788 on semaglutide, about $1,300 more than welludr's locked $492 - the honest price of flexibility.
  • On tirzepatide, TrimRx's $259 is beaten by $60/month at HealthRx ($199 after a $39 first month), a gap that compounds over a year.

The price, and the discount already inside it

At a glanceTrimRx (Trim Rx) runs $149/month for compounded semaglutide - a $140 discount already applied, the same price at every dose - and $259/month for tirzepatide, with medication, provider consultations and ongoing clinical support included. No long-term contract; multi-month plans lower the monthly further.

Self-pay, no insurance, 100% online. The number to anchor on: staying month-to-month costs $149 with total freedom to stop; committing several months at once trades some of that freedom for a lower rate - TrimRx is unusual in letting you choose per renewal rather than at signup.

Same tier, different products: TrimRx vs Medvi

The market moved these two apart: TrimRx's $149 semaglutide faces Medvi at a $99 promotional rate - and they sell nearly opposite products. Medvi spends the money on high-touch care: video visits, a dietician, coaching. TrimRx spends it on flexibility: no contract, optional discounts, a leaner clinical-support model. The choice is about what you value - the full head-to-head is in Medvi vs TrimRx.

ProviderSemaglutideTirzepatideModel
welludr$41/mo$71/mo12-mo lock for best rate
embody$49/mo$99/moFlat, no commitment
altRx$89/mo$149/moFlat + brand shelf
HealthRx$125/mo*$199Monthly plan, $39 first month
DirectMeds$249/mo (sublingual)Not published$249 sublingual; $297 injections
TrimRx$149/mo$259/moNo contract, opt-in discounts
Medvi$99/mo promo (reg. $199)$166/mo promo (reg. $299)All-inclusive high-touch

*After a $39 first month. One column worth a second look: on tirzepatide, TrimRx's $259 is beaten by $112/month at DirectMeds - if tirzepatide is your medication, that gap compounds fast.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

How do TrimRx's multi-month discounts work?

TrimRx's discount structure rewards commitment without demanding it, and the mechanics matter when budgeting. Month-to-month, you pay the listed $149/$259 with the right to stop at any renewal. Choose a multi-month plan and the per-month rate drops below the listed price - the exact rates are shown at signup and vary by plan length. The strategic play most patients miss: these aren't mutually exclusive forever. Start month-to-month while you and your clinician confirm the medication and dose suit you - the first 8-12 weeks answer that - then switch to a multi-month rate once the uncertainty is gone. You pay a small premium for exactly the months where flexibility has value, and stop paying it the moment it doesn't.

One number to keep handy while deciding: the titration timeline in how long semaglutide takes to work - it tells you when your own uncertainty window closes.

What does a flexible year at TrimRx cost?

Month-to-month for a year: $1,788 (semaglutide). Against welludr's locked $492, flexibility costs about $1,300/year - the honest number to stare at. It's worth paying when your circumstances genuinely might change: income uncertainty, a possible switch to brand-name, or you're still confirming the medication suits you in the first months. It's not worth paying indefinitely: once you know you're staying, either take TrimRx's own multi-month discount or move down-market. Flexibility you no longer need is just margin you're donating.

→ Current plans and multi-month rates in the TrimRx review

This article is general information, not medical advice. Prices as listed at the time of writing - confirm current pricing on the provider's site.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)